Trial NCT01166126

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-02846
Secondary IDs: 8436 MCC-16066 NCI-2012-02846 P30CA076292

Last trial update was posted on 2014-05-15

MeSH Interventions

MTOR Inhibitors Sirolimus Temsirolimus

MeSH Conditions

Melanoma

Other Conditions

Mucosal Melanoma Recurrent Melanoma Stage IV Melanoma

Stopping Reasons

N/A

Limitations And Caveats

The study was terminated due to overall low accrual and a high rate of screening failures. Accrual goal was 38 participants and only 4 participants were actually treated.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID